ADMA Biologics Inc (ADMA)
Inventory turnover
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 195,502 | 177,944 | 171,639 | 169,273 | 162,260 | 151,071 | 133,774 | 118,814 | 105,881 | 94,743 | 87,440 | 79,769 | 76,009 | 67,569 | 62,232 | 61,291 | 53,872 | 49,933 | 46,928 | 39,504 |
Inventory | US$ in thousands | 171,800 | 179,810 | 177,732 | 172,906 | 163,116 | 161,780 | 163,985 | 163,280 | 162,914 | 146,075 | 139,146 | 124,724 | 114,123 | 99,700 | 94,146 | 81,536 | 69,753 | 56,001 | 52,289 | 53,065 |
Inventory turnover | 1.14 | 0.99 | 0.97 | 0.98 | 0.99 | 0.93 | 0.82 | 0.73 | 0.65 | 0.65 | 0.63 | 0.64 | 0.67 | 0.68 | 0.66 | 0.75 | 0.77 | 0.89 | 0.90 | 0.74 |
September 30, 2024 calculation
Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $195,502K ÷ $171,800K
= 1.14
Inventory turnover measures how many times a company's inventory is sold and replaced during a specific period. A higher inventory turnover ratio indicates that the company is selling its inventory quickly and efficiently.
In the case of ADMA Biologics Inc, the inventory turnover ratio has fluctuated over the past few years. In the latest period, ending September 30, 2024, the inventory turnover ratio was 1.14, indicating an increase from the previous quarter. This suggests that ADMA Biologics Inc was able to sell and replace its inventory more frequently during this period.
Looking at the trend over the past few quarters, the inventory turnover has shown some volatility but overall has remained relatively stable. The company's inventory turnover ratio has generally been below 1, implying that the company is not turning over its inventory as quickly as some of its peers in the industry.
It is important for ADMA Biologics Inc to monitor its inventory turnover ratio closely and work towards improving it to ensure efficient management of its inventory and working capital. This could involve better demand forecasting, inventory management practices, and streamlining supply chain operations to enhance sales and reduce carrying costs associated with holding excess inventory.
Peer comparison
Sep 30, 2024
Sep 30, 2024